Dr. Jurre den Haan is a resident in Neurology and postdoctoral researcher at Amsterdam University Medical Center, location VUMC, in the Netherlands. He received his medical degree in 2014 and subsequently started his PhD at the Alzheimer Center Amsterdam focused on searching retinal biomarkers for Alzheimer’s disease. Over the course of his PhD he collected retinal data in AD patients with in-vivo methods in the form of optical coherence tomography (angiography) (OCT(A)), fundus photography and fluorescence imaging. In addition he worked on several post-mortem projects assessing pathological hallmarks of AD in the retina and the use of curcumin as fluorescent marker for amyloid pathology. During his PhD he was a visiting researcher at Queen’s Square Neurology in London, the United Kingdom, where he focused on retinal thickness measured with OCT in posterior cortical atrophy an typical Alzheimer’s disease. In 2019, he defended his thesis ‘Retinal Imaging in Alzheimer’s Disease’ and started his clinical work in Neurology. Observing the heterogeneity in the emerging research field of retinal imaging in AD he was involved in forming the new Personal Interest Area (PIA) ‘The Eye as a Biomarker for AD’, and was installed as junior chair.